Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

ClinicalTrials.gov ID: NCT02971891

Public ClinicalTrials.gov record NCT02971891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of six (6) weeks of once daily application of Furosemide Topical Gel 0.125% (CLS006) compared to vehicle in subjects ≥ 2 years of age with nongenital cutaneous common warts (verruca vulgaris).

Study identification

NCT ID
NCT02971891
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Maruho Co., Ltd.
Industry
Enrollment
484 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2017 (Type not available)
Primary completion
Apr 16, 2018 (Actual)
Completion
Jul 10, 2018 (Actual)
Last update posted
Sep 14, 2023

2017 – 2018

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Glendale Arizona 85308 —
Not listed Los Angeles California 90045 —
Not listed Santa Monica California 90404 —
Not listed Santa Rosa California 95403 —
Not listed Denver Colorado 80220 —
Not listed Miami Florida 33137 —
Not listed North Miami Beach Florida 33162 —
Not listed Ormond Beach Florida 32174 —
Not listed Tampa Florida 33624 —
Not listed Plainfield Indiana 46168 —
Not listed Lake Charles Louisiana 70605 —
Not listed Monroe Louisiana 71203 —
Not listed Hunt Valley Maryland 21030 —
Not listed Beverly Massachusetts 01915 —
Not listed Fort Gratiot Michigan 480059 —
Not listed Omaha Nebraska 68144 —
Not listed Portsmouth New Hampshire 03801 —
Not listed New York New York 10022 —
Not listed High Point North Carolina 27262 —
Not listed Wilmington North Carolina 28405 —
Not listed Fort Washington Pennsylvania 19034 —
Not listed Hazleton Pennsylvania 18201 —
Not listed Austin Texas 78759 —
Not listed College Station Texas 77845 —
Not listed Katy Texas 77494 —
Not listed San Antonio Texas 78213 —
Not listed San Antonio Texas 78229 —
Not listed Salt Lake City Utah 84117 —
Not listed Lynchburg Virginia 24501 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02971891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02971891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →